Humoral antibody responses to different H5N1 and H5N2 vaccination regimes: Implications for the development of autogenously based vaccines

Veterinary Microbiology

Volumn 153, Issue 3-4, 2011, Pages 398-402

  Shany, Salama A S ^a   El Kady, Magdy F ^a   Eid, Bahaa T M ^a   Hassan, Eman R ^b   Abdel Moneim, Ahmed S ^a,c  

^a Beni Suef University   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c TAIF UNIVERSITY   (Saudi Arabia)

Author keywords

Avian influenza; Chicken; H5N1; Vaccine

Indexed keywords

AUTOVACCINE; H5N1 VACCINE; H5N2 VACCINE; HEMAGGLUTININ; HUMORAL ANTIBODY; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ASSAY; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS BREEDING; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N2; NONHUMAN; ORTHOMYXOVIRUS INFECTION; OUTCOME ASSESSMENT; SCREENING; SEROLOGY; SERUM BACTERICIDAL ANTIBODY ASSAY; SINGLE DRUG DOSE; VACCINATION; VIRUS ISOLATION;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; VACCINATION;

AVES;

EID: 80053130701     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.06.006     Document Type: Article

References (20)

1. Abdel-Moneim A.S., Abdel-Gawad M.M.A. Genetic variations in maternal transfer and immune responsiveness to infectious bursal disease virus. Vet. Microbiol. 2006, 114:16-24.
2. Balish A.L., Davis C.T., Saad M.D., El-Sayed N., Esmat H., Tjaden J.A., Earhart K.C., Ahmed L.E., Abd El-Halem M., Ali A.H., Nassif S.A., El-Ebiary E.A., Taha M., Aly M.M., Arafa A., O'Neill E., Xiyan X., Cox N.J., Donis R.O., Klimov A.I. Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt. Avian Dis. 2010, 54:329-334.
3. Beard C.W. Serological procedures. A Laboratory Manual for the Isolation and Identification of Avian Pathogens 1989, 192-200. Kendall-Hunt Publishing, Dubuque, IO. H. Friedman (Ed.).
4. Belshe R.B., Cruber W.C., Mendelman P.M., Mehta H.B. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis. 2000, 181:1133-1137.
5. Bertelsen M.F., Klausen J., Holm E., Grondahl C., Jorgensen P.H. Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine. Vaccine 2007, 25:4345-4349.
6. Clements M.L., Betts R.F., Tierney E.F., Murphy B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild type virus. J. Clin. Microbiol. 1986, 24:157-160.
7. Eid, B.T.M., 2009. Serological and virological studies on avian influenza in Egypt. Ph.D. Beni-Suef University, Beni-Suef, Egypt.
8. Goetz S.K., Spackman E., Hayhow C., Swayne D.E. Assessment of reduced vaccine dose on efficacy of an inactivated avian influenza vaccine against an H5N1 high pathogenicity avian influenza virus. J. Appl. Poult. Res. 2008, 17:145-150.
9. Gyles N.R., Fallah-Moghaddam H., Patterson L.T., Skeeles J.K., Whitfill C.E., Johnson L.W. Genetic aspects of antibody responses in chickens to different classes of antigens. Poult. Sci. 1986, 65:223-232.
10. Hassan M.K., Afifi M.A., Aly M.M. Susceptibility of vaccinated and unvaccinated Egyptian chickens to very virulent infectious bursal disease virus. Avian Pathol. 2002, 31:149-156.
11. Kim J.K., Seiler P., Forrest H.L., Khalenkov A.M., Franks J., Kumar M., Karesh W.B., Gilbert M., Sodnomdarjaa R., Douangngeun B., Govorkova E.A., Webster R.G. Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks. J. Virol. 2008, 82:11374-11382.
12. Kempe A., Hall C.B., Mc Donald N.E., Foye H.R., Woodin K.A., Cohen H.J., Lewis E.D., Gullace M., Gala C.L., Dulberg C.S., Katsanis E. Influenza in children with cancer. J. Pediat. 1989, 115:33-39.
13. Lee C.W., Senne D.A., Suarez D.L. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J. Virol. 2004, 78:8372-8381.
14. Morley P.S., Hanson L.K., Bogdan J.R., Townsend H.G., Appleton J., Haines D. The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses. Vet. Microbiol. 1995, 45:81-92.
15. Peleg B.A., Soller M., Ron N., Hornstein K., Brody T., Kalmar E. Familial differences in antibody response of broiler chickens to vaccination with attenuated and inactivated Newcastle disease virus vaccine. Avian Dis. 1976, 20:661-668.
16. Potter C.W., Oxford J.S. Determinants of immunity to influenza infection in man. Br. Med. Bull. 1979, 35:69-75.
17. Sasaki T., Isoda N., Soda K., Sakamoto R., Saijo K., Hagiwara J., Kokumai N., Ohgitani T., Imamura T., Sawata A., Lin Z., Sakoda Y.H.K. Evaluation of the potency, optimal antigen level and lasting immunity of inactivated avian influenza vaccine prepared from H5N1 virus. Jpn. J. Vet. Res. 2009, 56:189-198.
18. Swayne D.E., Beck J.R., Garcia M., Stone H.D. Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines. Avian Pathol. 1999, 28:245-255.
19. Tian G., Zhang S., Li Y., Bu Z., Liu P., Zhou J., Li C., Shi J., Yu K., Chen H. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 2005, 341:153-162.
20. Tumpey T.M., Kapczynski D.R., Swayne D.E. Comparative susceptibility of chickens and turkeys to avian influenza A H7N2 virus infection and protective efficacy of a commercial avian influenza H7N2 virus vaccine. Avian Dis. 2004, 48:167-176.